article thumbnail

Veozah the New Drug for Menopausal Hot Flashes + SkinVive the New Dermal Filler — Xtalks Life Science Podcast Ep. 111

XTalks

In this episode, Vera talked about the US Food and Drug Administration’s (FDA) approval of Veozah (fezolinetant), the new type of drug for menopausal hot flashes and night sweats. The team discussed Veozah and the benefits of this drug for women’s health. during or after the menopausal transition.

Filler 52
article thumbnail

BONESUPPORT CEO Emil Billbäck Shares Insights About Cerament G, the New Bone Void Filler Launching in the US

XTalks

BONESUPPORT has recently received market authorization from the US Food and Drug Administration (FDA) for Cerament G, its bone graft with antibiotic elution. Xtalks learned more about BONESUPPORT and its first FDA-approved drug-device combination product Cerament G through an email interview with BONESUPPORT’s CEO Emil Billbäck.

Filler 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Some Talc Products Contain Asbestos: Study

The Pharma Data

30, 2020 – Nearly 15% of talc-based cosmetic products analyzed in a recent study contained asbestos. She noted that EWG’s online database has identified more than 2,000 personal care products that contain talc, including more than 1,000 loose or pressed powders that could pose an inhalation risk. MONDAY, Nov. based institute.

article thumbnail

New Section 804 Drug Import Rule Does Not Allow Foreign Versions of FDA-Approved Drugs

Pharmacy Checkers

The new federal rule on drug importation from Canada , drafted pursuant to Section 804 of the FDCA, does not allow for the importation of foreign versions of FDA-approved drugs. It only allows for the importation of FDA-approved drugs. Prescription Drug Importation.” Bollyky and Aaron S. It’s a different formulation.

article thumbnail

SkinVive by Juvéderm: The New Dermal Filler Coming to the US

XTalks

Allergan Aesthetics, an AbbVie company renowned for its development of leading aesthetics brands and products, recently announced the US Food and Drug Administration (FDA) approved their ground-breaking hyaluronic acid product, SkinVive by Juvéderm, for achieving remarkable skin smoothness.

Filler 92
article thumbnail

Novartis signs new initial agreement with BioNTech to support fill and finish of the mRNA Pfizer-BioNTech COVID-19 vaccine

The Pharma Data

Novartis blazoned moment that it has inked an original agreement to work its manufacturing capacity and capabilities to address the COVID-19 epidemic by expanding its support of the filler and finish of the Pfizer-BioNTech COVID-19 vaccine. About Novartis Novartis is reimagining drug to ameliorate and extend people’s lives.

article thumbnail

NuVasive’s Precice Limb Lengthening System Is Now an Option for Pediatric Patients

XTalks

recently announced that the company received 510(k) clearance from the US Food and Drug Administration (FDA) for the use of the Precice internal limb lengthening solution in pediatric patients. NuVasive, Inc. NuVasive is a leader in the field of spine technology, and has developed minimally disruptive solutions for spine surgery.

Filler 95